000 01953nam  2200301za 4500
0019.656229
003CaOODSP
00520210122073040
007ta
008150407s1993||||xxc|||||     f|0| 0 eng d
020 |a0-660-58996-6
040 |aCaOODSP|beng
041 |aeng
041 |afre
043 |an-cn---
0861 |aZ1-1989/3-3
1101 |aCanada.|bRoyal Commission on New Reproductive Technologies.
24510|aProceed with care : |bfinal report of the Royal Commission on New Reproductive Technologies: summary & highlights / |cChairperson: Patricia Baird.
260 |aOttawa - Ontario : |bRoyal Commissions. |c1993.
300 |aEnglish text, 26p. ; |c23 cm.
5203 |aTest tube babies, fertility drugs, egg and embryo donation, womb rental, gene therapy and sex selection are all issues fraught with implications -- social, ethical, legal, health, scientific and economic. As science continually pushes forward the frontiers of reproductive technology, more Canadians realize that such technology can be misused, with harmful consequences for individuals and for society. The work of the commission, chaired by Patricia Baird, spanned four years of intensive research, consultation and deliberation. The result is a report with an exhaustive analysis of the issues and a set of far-reaching recommendations. While the Commission concluded that some reproductive technologies and some of their uses are unethical and contrary to Canadians' values, it found that others are potentially beneficial, if used ethically and responsibly. Hence the need for a system to oversee, licence, and monitor activities in this field, which is outlined in the report.
546 |aBilingual
563 |aSoftcover
590 |a94-02|b1994-01-14
69007|aReproductive technology|2gcpds
7201 |aBaird, Patricia
7760#|tProceed with care : |w(CaOODSP)9.895500
792 |tUn virage à prendre en douceur : |w(CaOODSP)9.656230